title: Cardiovascular safety and diabetes drug development.
authors.affiliation: Department of Medicine, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. d.drucker@utoronto.ca
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Drucker
authors.forename: Allison B
authors.initials: AB
authors.lastname: Goldfine
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D017277:Drug Approval; D015195:Drug Design; D017408:Guidelines as Topic; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D055118:Medication Adherence; D018027:Receptors, Glucagon / Q000819:agonists; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007004:Hypoglycemic Agents; D018027:Receptors, Glucagon